Published • loading... • Updated
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?
Summary by 24/7 Wall St.
1 Articles
1 Articles
Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold?
The post Eli Lilly, Novo Nordisk and Merck: Buy, Sell or Hold? appeared first on 24/7 Wall St.. Among the pharma names investors debate most, Eli Lilly (NYSE:LLY) at $1,216.46 screens most constructively, Novo Nordisk (NYSE:NVO) at $45.92 looks range-bound, and Merck (NYSE:MRK) at $135.97 screens as fairly valued. All three trade in a market obsessed with GLP-1 economics and Merck’s KEYTRUDA patent cliff, and each has priced in a very different …
·Lakewood, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
